Gasparini G - Search Results

1

Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.

Gasparini G, Meli S, Panizzoni GA, Visonà A, Boracchi P, Bevilacqua P, Marubini E, Pozza F. Gasparini G, et al. Breast Cancer Res Treat. 1992 Mar;20(3):195-204. doi: 10.1007/BF01834625. Breast Cancer Res Treat. 1992. PMID: 1571572

2

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.

Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JR, Meli S, Boracchi P, Testolin A, La Malfa G, Pozza F. Gasparini G, et al. J Clin Oncol. 1992 May;10(5):686-95. doi: 10.1200/JCO.1992.10.5.686. J Clin Oncol. 1992. PMID: 1349034

3

PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma.

Gasparini G, Meli S, Pozza F, Cazzavillan S, Bevilacqua P. Gasparini G, et al. Growth Regul. 1992 Dec;2(4):145-50. Growth Regul. 1992. PMID: 1363282

4

Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer.

Gasparini G, Pozza F, Dittadi R, Meli S, Cazzavillan S, Bevilacqua P. Gasparini G, et al. J Cancer Res Clin Oncol. 1992;118(7):557-63. doi: 10.1007/BF01225273. J Cancer Res Clin Oncol. 1992. PMID: 1378057

5

Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.

Gasparini G, Bevilacqua P, Pozza F, Meli S, Boracchi P, Marubini E, Sainsbury JR. Gasparini G, et al. Br J Cancer. 1992 Nov;66(5):970-6. doi: 10.1038/bjc.1992.394. Br J Cancer. 1992. PMID: 1419645 Free PMC article.

6

Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomas.

Gasparini G, Reitano M, Bevilacqua P, Meli S, Pozza F, Santini G. Gasparini G, et al. Anticancer Res. 1991 Jul-Aug;11(4):1597-603. Anticancer Res. 1991. PMID: 1746917

7

Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.

Gasparini G, Pozza F, Meli S, Reitano M, Santini G, Bevilacqua P. Gasparini G, et al. Anticancer Res. 1991 Nov-Dec;11(6):2015-21. Anticancer Res. 1991. PMID: 1776834

8

Characterization of node-negative breast cancer by clinico-pathologic and biologic factors.

Gasparini G, Bevilacqua P, Dal Fior S, Panizzoni GA, Favretto S, Visonà A, Meli S. Gasparini G, et al. Anticancer Res. 1990 Jan-Feb;10(1):205-8. Anticancer Res. 1990. PMID: 2334128

9

Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma.

Gasparini G, Dal Fior S, Pozza F, Bevilacqua P. Gasparini G, et al. Breast Cancer Res Treat. 1989 Dec;14(3):329-36. doi: 10.1007/BF01806305. Breast Cancer Res Treat. 1989. PMID: 2482095

10

Immunocytochemical detection of progesterone receptor by monoclonal KD-68 antibody in operable breast cancer: correlations with biochemical assay, pathological features and cell proliferative rate.

Bevilacqua P, Pea M, Gasparini G. Bevilacqua P, et al. Among authors: gasparini g. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1595-602. doi: 10.1016/0277-5379(89)90303-9. Eur J Cancer Clin Oncol. 1989. PMID: 2687004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

892 results

Search Page

Filters